Cargando…
Heterogeneous multimodal biomarkers analysis for Alzheimer’s disease via Bayesian network
By 2050, it is estimated that the number of worldwide Alzheimer’s disease (AD) patients will quadruple from the current number of 36 million, while no proven disease-modifying treatments are available. At present, the underlying disease mechanisms remain under investigation, and recent studies sugge...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992017/ https://www.ncbi.nlm.nih.gov/pubmed/27610127 http://dx.doi.org/10.1186/s13637-016-0046-9 |